Antares Pharma, Inc. (ATRS)

Sales/Maturities of Investments

$996.00K

Quarterly · Period ending: · USD

ATRS logo

ATRS Sales/Maturities of Investments

Latest reported$996.00K
ATRS Quarterly Sales/Maturities of Investments ($0.00 → $996.00K)
High-resolution chart · PNG

ATRS sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.